Wide Ranks

ADIL

Adial Pharmaceuticals, Inc

0.9910

Top Statistics
Market Cap 6 M Forward PE -0.7004 Revenue Growth 0.00 %
Current Ratio 5.69 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.5520 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.5130 Total Debt
Total Debt To Equity Current Ratio 5.69 Book Value Per Share 2.46
All Measures
Short Ratio 65.00 % Message Board Id finmb_112638788 Shares Short Prior Month 77821
Return On Equity -3.21 City Glen Allen Uuid a144d6a7-1775-3bb1-b1ca-599a0edca1eb
Previous Close 1.00 First Trade Date Epoch Utc 1 B Book Value 2.46
Beta 1.30 Volume 135978 Price To Book 0.4037
Last Split Date 1 B Fifty Two Week Low 0.7700 Total Cash Per Share 0.5130
Shares Short Previous Month Date 1 B Target Median Price 7.50 Max Age 86400
Recommendation Mean 1.67 Sand P52 Week Change 0.3133 Target Mean Price 7.50
Net Income To Common -12186995 Short Percent Of Float 0.0125 Implied Shares Outstanding 6 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 316760
Average Volume10days 316760 Total Cash 3 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0180 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.00 Target Low Price 7.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.02 Open 1.02
Free Cashflow -2989877 State VA Dividend Yield 0.00 %
Return On Assets -1.04 Time Zone Short Name EST Trailing Eps -2.94
Day Low 0.9800 Address1 4870 Sadler Road Shares Outstanding 6 M
Price Hint 4 Target High Price 8.00 Website https://www.adialpharma.com
52 Week Change -0.5479 Average Volume 143418 Forward Eps -1.33
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 489.40 %
Last Split Factor 1:25 Regular Market Day High 1.02 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 4.17 Day High 1.02
Shares Short 78882 Regular Market Open 1.02 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0123
Operating Cashflow -6387939 Currency USD Time Zone Full Name America/New_York
Market Cap 6 M Is_nasdaq_100 False Zip 23060
Quote Type EQUITY Industry Biotechnology Long Name Adial Pharmaceuticals, Inc.
Regular Market Day Low 0.9800 Held Percent Institutions 0.0303 Current Price 0.9910
Address2 Suite 300 Enterprise To Ebitda -0.5520 Financial Currency USD
Current Ratio 5.69 Industry Disp Biotechnology Number Of Analyst Opinions 2
Country United States Float Shares 6 M Two Hundred Day Average 1.27
Enterprise Value 4 M Forward PE -0.7004 Regular Market Volume 135978
Ebitda -7273465 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder.

It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders.

The company was founded in 2010 and is based in Glen Allen, Virginia.